INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
97 hedge funds and large institutions have $82.5M invested in Infinity Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
-10
Holders Change %
-9.35%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
30
Reduced
32
Closed
19
Calls
$2.88M
Puts
$655K
Net Calls
+$2.22M
Net Calls Change
-$1.23M
Top Buyers
| 1 |
GC
Gratus Capital
Atlanta,
Georgia
|
+$2.15M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.73M |
| 3 |
BlackRock
New York
|
+$1.54M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.31M |
| 5 |
Renaissance Technologies
New York
|
+$713K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$4.97M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$4.57M |
| 3 |
GPC
Guardian Point Capital
Charlottesville,
Virginia
|
-$4.1M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.89M |
| 5 |
Two Sigma Investments
New York
|
-$2.18M |
